Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03294486
Title Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (ONCOVIRAC)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Assistance Publique - Hôpitaux de Paris



Flucytosine + TG6002

Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.